21
Oct 2026
A nine-year study reveals a pattern linking loneliness to heart risk
The study reveals that patterns of loneliness and social isolation significantly impact heart health, suggesting new avenues for cardiovascular risk assessment.
Stay Informed!
21
Oct 2026
Oxaloacetate supplement may help reduce chemo brain in breast cancer survivors
A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement containing oxaloacetate, a molecule naturally found in the body that helps cells produce energy, may help improve cognitive function and reduce the fatigue experienced by some breast cancer survivors following treatment.
21
Oct 2026
Could a hormone from our bones reveal early signs of insulin resistance?
Research reveals a link between osteocalcin and insulin resistance in obese children, suggesting early metabolic changes before glucose tolerance impairment.
21
Oct 2026
All-in-One solution for continuous microbial monitoring without production interruptions
Particle Measuring Systems (PMS), a global leader in contamination monitoring solutions, today announced the launch of the BioCapt® Single-Use STS Microbial Monitor, a sterile transfer solution that enables the introduction of viable air monitoring consumables into isolators and Restricted Access Barrier Systems (RABS) without requiring additional decontamination activities.
21
Oct 2026
Touchlight announces leadership transition, with Will Downie appointed interim CEO
Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.
21
Oct 2026
Qureight appointed imaging CRO for Phase 3 SURPASS-IPF trial as partnership with Celea Therapeutics expands
Qureight, an end-to-end imaging CRO providing enterprise-grade imaging and precision endpoints for clinical trials for lung and heart disease, today announced it has been selected by Celea Therapeutics as the imaging CRO to support Celea’s Phase 3 SURPASS-IPF clinical trial.
21
Oct 2026
Why did people report feeling better during COVID-19? A French study offers clues
Assessing well-being in France (2014-2023), the study finds COVID-19 influenced scores, with health symptoms significantly affecting emotional health.
21
Oct 2026
Young adults increasingly use high-nicotine e-cigarettes, study finds
Researchers from University of California San Diego Herbert Wertheim School of Public Health and Human Longevity Science have found that high-nicotine e-cigarette use rose sharply among young adults between 2017 and 2022 and was associated with increased nicotine dependence and more persistent vaping.
21
Oct 2026
Duke initiative aims to bring dementia AI tools into clinical practice
Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice.
21
Oct 2026
Diverse social activities may help slow age-related cognitive decline
Diverse and sustained social activities may boost cognitive performance and slow the decline in brain health associated with aging, suggest the findings of a large international study, published online in the Journal of Epidemiology & Community Health.
